INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company

Phio Pharmaceuticals Corp.

Filed

March 4, 2025

Period of Report

February 19, 2025

Accession Number

0001062993-25-004347